Kang, M.-A.; Lee, J.; Lee, C.M.; Park, H.S.; Jang, K.Y.; Park, S.-H.
IL13Rα2 Is Involved in the Progress of Renal Cell Carcinoma through the JAK2/FOXO3 Pathway. J. Pers. Med. 2021, 11, 284.
https://doi.org/10.3390/jpm11040284
AMA Style
Kang M-A, Lee J, Lee CM, Park HS, Jang KY, Park S-H.
IL13Rα2 Is Involved in the Progress of Renal Cell Carcinoma through the JAK2/FOXO3 Pathway. Journal of Personalized Medicine. 2021; 11(4):284.
https://doi.org/10.3390/jpm11040284
Chicago/Turabian Style
Kang, Mi-Ae, Jongsung Lee, Chang Min Lee, Ho Sung Park, Kyu Yun Jang, and See-Hyoung Park.
2021. "IL13Rα2 Is Involved in the Progress of Renal Cell Carcinoma through the JAK2/FOXO3 Pathway" Journal of Personalized Medicine 11, no. 4: 284.
https://doi.org/10.3390/jpm11040284
APA Style
Kang, M.-A., Lee, J., Lee, C. M., Park, H. S., Jang, K. Y., & Park, S.-H.
(2021). IL13Rα2 Is Involved in the Progress of Renal Cell Carcinoma through the JAK2/FOXO3 Pathway. Journal of Personalized Medicine, 11(4), 284.
https://doi.org/10.3390/jpm11040284